TotalMarketCap

CG Oncology

CGONNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$5.743 B

$64.79 -4.31%

Close of 6 Nov 2026

As of 6 Nov 2026, CG Oncology (CGON) has a market capitalization of $5.74B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$161.0M

Loss-making

Shares outstanding

89,318,916

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #18Twist BioscienceTWST$7.95B
  2. #19ImmunovantIMVT$5.87B
  3. #20CG OncologyCGON$5.74B
  4. #21Kodiak SciencesKOD$5.73B
  5. #22Scholar RockSRRK$5.56B

What if CG Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$318,555.44

Per share 4,917× higher

Bitcoin $1.53T

$17,236.48

Per share 266× higher

Apple $5.02T

$56,585.76

Per share 873× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for CG Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.